Clinical Development of Anti-TIGIT Antibodies for Immunotherapy of Cancer

被引：0
|
作者：
Vaia Florou
Ignacio Garrido-Laguna
机构：
来源：
Current Oncology Reports | 2022年 / 24卷
关键词：
TIGIT; anti-TIGIT antibodies; immunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1107 / 1112
页数：5
相关论文
共 50 条
  • [1] Clinical Development of Anti-TIGIT Antibodies for Immunotherapy of Cancer
    Florou, Vaia
    Garrido-Laguna, Ignacio
    [J]. CURRENT ONCOLOGY REPORTS, 2022, 24 (09) : 1107 - 1112
  • [2] Functional Anti-TIGIT Antibodies Regulate Development of Autoimmunity and Antitumor Immunity
    Dixon, Karen O.
    Schorer, Michelle
    Nevin, James
    Etminan, Yassaman
    Amoozgar, Zohreh
    Kondo, Takaaki
    Kurtulus, Sema
    Kassam, Nasim
    Sobel, Raymond A.
    Fukumura, Dai
    Jain, Rakesh K.
    Anderson, Ana C.
    Kuchroo, Vijay K.
    Joller, Nicole
    [J]. JOURNAL OF IMMUNOLOGY, 2018, 200 (08): : 3000 - 3007
  • [3] Anti-TIGIT in the liver
    Landman, Allison
    [J]. LANCET ONCOLOGY, 2023, 24 (07): : 724 - 724
  • [4] Functional anti-TIGIT antibodies modulate T cell responses in vivo
    Dixon, K.
    Schorer, M.
    Nevin, J.
    Etminan, Y.
    Amoozgar, Z.
    Kondo, T.
    Kurtulus, S.
    Kassam, N.
    Sobel, R.
    Fukumura, D.
    Jain, R.
    Anderson, A.
    Kuchroo, V
    Joller, N.
    [J]. SWISS MEDICAL WEEKLY, 2018, 148 : 4S - 4S
  • [5] Targeting TIGIT for Immunotherapy of Cancer: Update on Clinical Development
    Rotte, Anand
    Sahasranaman, Srikumar
    Budha, Nageshwar
    [J]. BIOMEDICINES, 2021, 9 (09)
  • [6] TWO TYPES OF ANTI-TIGIT ANTIBODIES WITH DISTINCT BINDING EPITOPE AND FUNCTIONAL ACTIVITIES
    Zhong, Tingting
    Pang, Xinghua
    Huang, Zhaoliang
    Chen, Na
    Jin, Xiaoping
    Xia, Yu
    Wang, Maxwell Zhongmin
    Li, Baiyong
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A109 - A109
  • [7] Androgen deprivation therapy allows for effective anti-TIGIT immunotherapy in murine model of castration resistant prostate cancer
    Polesso, Fanny
    Guan, Xiangnan
    Xia, Zheng
    Moran, Amy E.
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [8] CD226hiCD8+ T Cells Are a Prerequisite for Anti-TIGIT Immunotherapy
    Jin, Hyung-seung
    Ko, Minkyung
    Choi, Da-som
    Kim, June Hyuck
    Lee, Dong-hee
    Kang, Seong-Ho
    Kim, Inki
    Lee, Hee Jin
    Choi, Eun Kyung
    Kim, Kyu-pyo
    Yoo, Changhoon
    Park, Yoon
    [J]. CANCER IMMUNOLOGY RESEARCH, 2020, 8 (07) : 912 - 925
  • [9] Phenotyping of TIGIT pathway members may be used for cancer selection in the clinical application of anti-TIGIT antibody EOS884448
    Wald, Noemie
    Cuende, Julia
    Mercier, Marjorie
    Nyawouame, Florence
    Brouwer, Margreet
    Houthuys, Erica
    Driessens, Gregory
    Bodo, Veronique
    Hoofd, Catherine
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [10] Prediction of intratumoral TIGIT receptor occupancy after the treatment with anti-TIGIT antibodie
    Shchelokov, Dmitry
    Demin, Oleg, Jr.
    Demin, Oleg
    Rizwan, Ahsan
    Zhang, Yun
    Tan, Wei
    Sahasranaman, Srikumar
    Budha, Nageshwar
    [J]. CANCER RESEARCH, 2022, 82 (12)
12345